Cleveland Clinic Taussig Cancer Institute
S

Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC

By Cleveland Clinic Taussig Cancer Institute FEATURING Suneel Kamath
By Cleveland Clinic Taussig Cancer Institute FEATURING Suneel Kamath
0 views
July 20, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Recommended

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

10:57
UCLA Health

Y90 Radioembolization for Locally Advanced HCC

Feat. S. Padia
15:30
Yale Cancer Center

Updates in Combination Therapy for HCC

Feat. S. Stein
26:59
University of Texas Southwestern Medical Center

2023 AASLD Guidance for HCC

Feat. A. Singal
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
13:58
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 &am…

Feat. R. Kim, T. Biachi
22:02
ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

Feat. R. Wong
25:09
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC…

Feat. R. Kim, T. Biachi
09:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary C…

Feat. N. Uboha, K. Spencer, M. Cecchini
14:14
Stanford Medicine

HCC: Updates in Management

Feat. R. Dhanasekaran
08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
15:53
Yale Cancer Center

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Feat. A. Jaffe
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
11:47
Johns Hopkins

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Feat. M. Baretti
28:59
The France Foundation

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

Feat. A. Smolock, B. George
19:39
The France Foundation

Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 …

Feat. A. Burgoyne, S. Stein
15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott
27:48
Lionel Kankeu Fonkoua

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…